New 20-Minute test could spot deadly virus at bedside
NCT ID NCT06624787
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new rapid diagnostic test for Crimean-Congo hemorrhagic fever (CCHF) that gives results in 20 minutes. Researchers will enroll 492 adults in Turkey with suspected CCHF to see if the test is accurate compared to standard lab methods. The goal is to provide a cheap, simple test that can be used in clinics to speed up diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Rapid diagnostic test (lateral flow device)
What this could lead to
If successful, this could provide a fast, cheap, and simple test for Crimean-Congo hemorrhagic fever at clinics, helping speed up diagnosis and treatment.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The test may not meet the required sensitivity or specificity in real-world use, and results may not apply outside Turkey.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRIMEAN-CONGO HAEMORRHAGIC FEVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atatürk University
RECRUITINGErzurum, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Erzurum City Hospital
RECRUITINGErzurum, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Kastamonu Üniversitesi
RECRUITINGKastamonu, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Ondokuz Mayis University (OMU) Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Samsun
RECRUITINGSamsun, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Sivas Cumhuriyet University
RECRUITINGSivas, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Tokat Gaziosmanpaşa University
RECRUITINGTokat Province, Turkey (Türkiye)
Contact Email: •••••@•••••